The Elecsys pTau217 test can help doctors assess amyloid pathology in people 55 and older showing signs of cognitive decline

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings